- Ponzetti M, Rucci N. Switching homes: How cancer
moves to bone. Int J Mol Sci 2020; 21(11):4124. doi:
10.3390/ijms21114124.
2. Green D, Eyre H, Singh A, et al. Targeting the MAPK7/
MMP9 axis for metastasis in primary bone cancer.
Oncogene 2020; 39(33):5553-69. 10.1038/s41388-
020-1379-0.
3. Mukaida N, Zhang D, Sasaki SI. Emergence of cancerassociated fibroblasts as an indispensable cellular
player in bone metastasis process. Cancers (Basel)
2020; 12(10):2896. doi: 10.3390/cancers12102896.
4. van de Merbel AF, van Hooij O, van der Horst G, et
al. The identification of small molecule inhibitors
that reduce invasion and metastasis of aggressive
cancers. Int J Mol Sci 2021; 22(4):1688. doi: 10.3390/
ijms22041688.
5. Li Y, Long X, Wang J, Peng J, Shen K. miRNA-128
modulates bone neoplasms cells proliferation and
migration through the WNT/beta-catenin and EMT
signal pathways. J Orthop Surg Res. 2021; 16(1):71.
doi: 10.1186/s13018-020-02164-w.
6. Lin WH, Chang YW, Hong MX, et al. STAT3
phosphorylation at Ser727 and Tyr705 differentially
regulates the EMT-MET switch and cancer metastasis.
Oncogene. 2021; 40(4):791-805. doi: 10.1038/
s41388-020-01566-8 7. Nastały P, Stoupiec S, Popęda M, et al. EGFR as a stable
marker of prostate cancer dissemination to bones.
Br J Cancer 2020; 123(12):1767-74. doi: 10.1038/
s41416-020-01052-8.
8. Lin SR, Mokgautsi N, Liu YN. Ras and Wnt interaction
contribute in prostate cancer bone metastasis.
Molecules. 2020; 25(10):2380. doi: 10.3390/
molecules25102380.
9. Tseng JC, Huang SH, Lin CY, et al. ROR2 suppresses
metastasis of prostate cancer via regulation of miR199a-5p-PIAS3-AKT2 signaling axis. Cell Death Dis.
2020; 11(5):376. doi: 10.1038/s41419-020-2587-9.
10.Wang C, Wang J, Chen K, et al. Caprylic acid (C8:0)
promotes bone metastasis of prostate cancer by
dysregulated adipo-osteogenic balance in bone
marrow. Cancer Sci 2020; 111(10):3600-12. doi:
10.1111/cas.14606.
11.Owen KL, Gearing LJ, Zanker DJ, et al. Prostate cancer
cell-intrinsic interferon signaling regulates dormancy
and metastatic outgrowth in bone. EMBO Rep 2020;
21(6):e50162. doi: 10.15252/embr.202050162.
12.Karlsson R, Larsson P, Miftakhova R, et al. Establishment
of prostate tumor growth and metastasis is supported
by bone marrow cells and is mediated by PIP5K1alpha
lipid kinase. Cancers (Basel) 2020; 12(9):2719. doi:
10.3390/cancers12092719.
13.Sawada Y, Kikugawa T, Iio H, et al. GPRC5A facilitates
cell proliferation through cell cycle regulation and
correlates with bone metastasis in prostate cancer.
Int J Cancer 2020; 146(5):1369-82. doi: 10.1002/
ijc.32554.
14.Misawa A, Kondo Y, Takei H, Takizawa T. Long
noncoding RNA HOXA11-AS and transcription factor
HOXB13 modulate the expression of bone metastasisrelated genes in prostate cancer. Genes (Basel) 2021;
12(2):182. doi: 10.3390/genes12020182.
15.Jiang W, Rixiati Y, Huang H, Shi Y, Huang C, Jiao B.
Asperolide A prevents bone metastatic breast cancer
via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling
pathway. Cancer Med. 2020; 9(21):8173-85. doi:
10.1002/cam4.3432.
16.Mandal CC. Osteolytic metastasis in breast
cancer: effective prevention strategies. Expert
Rev Anticancer Ther 2020; 20(9):797-811. doi:
10.1080/14737140.2020.1807950.
17.Bishop RT, Marino S, Carrasco G, et al. Combined
administration of a small-molecule inhibitor of
TRAF6 and Docetaxel reduces breast cancer skeletal
metastasis and osteolysis. Cancer Lett 2020; 488:27-
39. doi: 10.1016/j.canlet.2020.05.021.
18.Liu S, Song A, Zhou X, et al. ceRNA network development
and tumour-infiltrating immune cell analysis of
metastatic breast cancer to bone. J Bone Oncol 2020;
24:100304. doi: 10.1016/j.jbo.2020.100304.
19.Salamanna F, Borsari V, Pagani S, Brodano
GB, Gasbarrini A, Fini M. Development and
characterization of a novel human 3D model of
bone metastasis from breast carcinoma in vitro
cultured. Bone 2021; 143:115773. doi: 10.1016/j.
bone.2020.115773.
20.Eckhardt BL, Cao Y, Redfern AD, et al. Activation of
canonical BMP4-SMAD7 signaling suppresses breast
cancer metastasis. Cancer Res 2020;80(6):1304-15.
doi: 10.1158/0008-5472.CAN-19-0743.
21.Liu J, Feng J, Li L, et al. Arginine methylation-dependent
LSD1 stability promotes invasion and metastasis of
breast cancer. EMBO Rep 2020; 21(2):e48597. doi:
10.15252/embr.201948597.
22.Pang Y, Fu Y, Li C, et al. Metal-organic framework
nanoparticles for ameliorating breast cancerassociated osteolysis. Nano Lett 2020; 20(2):829-40.
doi: 10.1021/acs.nanolett.9b02916.
23.Park SB, Hwang KT, Chung CK, Roy D, Yoo C. Causal
Bayesian gene networks associated with bone,
brain and lung metastasis of breast cancer. Clin Exp
Metastasis 2020;37(6):657-74. doi: 10.1007/s10585-
020-10060-0.
24.Ma RY, Zhang H, Li XF, et al. Monocyte-derived
macrophages promote breast cancer bone metastasis
outgrowth. J Exp Med 2020; 217(11):e20191820. doi:
10.1084/jem.20191820.
25.Zhang X, Yu X, Zhao Z, et al. MicroRNA-429 inhibits
bone metastasis in breast cancer by regulating CrkL
and MMP-9. Bone 2020; 130:115139. doi: 10.1016/j.
bone.2019.115139.
26.Liu S, Song A, Wu Y, et al. Analysis of genomics
and immune infiltration patterns of epithelialmesenchymal transition related to metastatic breast
cancer to bone. Transl Oncol 2021; 14(2):100993.
doi: 10.1016/j.tranon.2020.100993.
27.Soni S, Torvund M, Mandal CC. Molecular insights
into the interplay between adiposity, breast cancer
and bone metastasis. Clin Exp Metastasis. 2021;
38(2):119-138. doi: 10.1007/s10585-021-10076-0.
28.Teng X, Wei L, Han L, Min D, Du Y. Establishment of
a serological molecular model for the early diagnosis
and progression monitoring of bone metastasis
in lung cancer. BMC Cancer 2020; 20(1):562. doi:
10.1186/s12885-020-07046-2.
29.Brunetti G, Belisario DC, Bortolotti S, et al. LIGHT/
TNFSF14 promotes osteolytic bone metastases in
non-small cell lung cancer patients. J Bone Miner Res
2020; 35(4):671-80. doi: 10.1002/jbmr.3942
|
